Topics


High-grade gliomas | Treatment | Targeted therapy






Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy






OVERVIEW






AUCELICICLIB

ANLOTINIB

APATINIB

AVAPRITINIB







BEVACIZUMAB










CAMRELIZUMAB










DABRAFENIB










FEXAGRATINIB










IPILIMUMAB










LAROTRECTINIB

LENVATINIB









NILOTINIB

NIVOLUMAB









OLAPARIB










PEMBROLIZUMAB










SAMOTOLISIB

SM-1

SORAFENIB

SYHA1813







TG02










TARG RADIONUCLIDE THERAPY

TERAMEPROCOL

TRAMETINIB








VEMURAFENIB

VORASIDENIB